Reports Q1 revenue $1.76B, consensus $1.65B. “We achieved better-than-expected results this quarter and fully restored overall market share, enabling us to maintain our sales outlook and raise our gross margin and EPS outlook for the year,” said Chair and CEO Linda Rendle. “As our consumers remain under pressure, we’re focused on delivering superior value, strong innovation and continued investment in our brands to win with consumers and grow share. Anchored by the strength of our portfolio and the advancement of our IGNITE strategy, we are confident we are taking the right steps to deliver consistent and profitable growth for the long-term.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CLX:
- Notable companies reporting after market close
- Is CLX a Buy, Before Earnings?
- Clorox price target raised to $174 from $148 at JPMorgan
- Clorox price target raised to $137 from $130 at Barclays
- Clorox upgraded to Buy from Hold at Jefferies
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
